INHIBITING SARM1 IS MORE EFFICACIOUS THAN NICOTINAMIDE RIBOSIDE SUPPLEMENTATION FOR THE TREATMENT OF A MOUSE MODEL WITH NAFLD/NASH
2023
Details
Title
INHIBITING SARM1 IS MORE EFFICACIOUS THAN NICOTINAMIDE RIBOSIDE SUPPLEMENTATION FOR THE TREATMENT OF A MOUSE MODEL WITH NAFLD/NASH
Author(s)
Liu, Yasmine ; Scantlebery, Angelique M. L. ; Strotjohann, Keno ; Rodriguez-Lopez, Sandra ; Li, Xiaoxu ; Homicsko, Krisztian ; Smith, Karen ; Ciavarri, Jeffrey ; Bou-Sleiman, Maroun ; Houtkooper, Riekelt H. ; Auwerx, Johan
Published in
Hepatology
Volume
78
Pages
S1108-S1108
Conference
Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), NOV 10-14, 2023, Boston, MA
Date
2023-10-01
Publisher
Lippincott Williams & Wilkins, Philadelphia
ISSN
0270-9139
1527-3350
1527-3350
Other identifier(s)
View record in Web of Science
Laboratories
LISP
Record Appears in
Scientific production and competences > SV - School of Life Sciences > IBI-SV - Interfaculty Institute of Bioengineering > LISP - Laboratory of Integrative Systems Physiology
Peer-reviewed publications
Conference Papers
Work produced at EPFL
Published
Peer-reviewed publications
Conference Papers
Work produced at EPFL
Published
Record creation date
2024-02-20